Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03860714
Other study ID # XYFY2019-KL015-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2019
Est. completion date May 30, 2020

Study information

Verified date February 2019
Source Xuzhou Medical University
Contact Junli Cao
Phone +86 15162160809
Email caojl0310@yahoo.com.cn
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This study intends to evaluate the relationship between urinary albumin/creatinine ratio and postoperative neurocognitive impairment in elderly non-cardiac surgery patients. The results of the study are to identify risk factors, screen high-risk populations to improve clinical evidence, early detection and early treatment.And reducing the burden of PNCD on patients and their families, hospitals and public resources.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date May 30, 2020
Est. primary completion date December 30, 2019
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria:

- Non-cardiac surgery patients;

- Age is greater than or equal to 60 years old; ?Han Nationality, mother tongue is chinese;

?The MMSE score:Illiteracy is greater than or equal to 17 points, primary school is greater than or equal to 20 points, higher secondary school is more than 24 points;

?The people signed informed consent.

Exclusion Criteria:

- The diagnosis of preoperative delirium;

- The diagnosis Unstable hypertension(Such as:pheochromocytoma or aortic dissection); ?Severe chronic obstructive pulmonary disease or congestive heart failure; ?Severe liver and kidney dysfunction;

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Neuropsychological tests
We do the neuropsychological tests, Mini-Mental score examination (MMSE),Charlson Comorbidity Index(CCI),Clinical Dementia Rating(CDR),Quality of Recovery Score - 40 (QoR-40),Geriatric Depression Scale (GDS),CAGE Alcoholism Questionnaire,Pure Tone Audiometry,blood albumin?hemoglobin content?ALT?AST?BUN?Cr?serum folic acid?vitamin B12?homocysteine and branched chain amino acid content 1 day before the surgery(baseline); 1 day before the surgery(baseline); Confusion Assessment Method(CAM),Numerical Rating Scale(NRS)once before discharge from PACU and 1?2?3 days after surgery twice a day; QoR-40 1 day after surgery; Neuropsychological tests and MMSE 6±1 days and one month after surgery.

Locations

Country Name City State
China Department of Anesthesia of the Affiliated Hospital of Xuzhou Medical University Xuzhou Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Han Yuan

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other blood Albumin levels Record preoperative blood Albumin levels before surgery(baseline)
Other blood Hemoglobin content Record preoperative blood Hemoglobin content before surgery(baseline)
Other blood Alanine aminotransferase (ALT) levels Record preoperative blood Alanine aminotransferase (ALT) levels before surgery(baseline)
Other blood Aspartate aminotransferase (AST)levels Record preoperative blood Aspartate aminotransferase (AST)levels before surgery(baseline)
Other Blood urea nitrogen(BUN) levels Record preoperative Blood urea nitrogen(BUN) levels before surgery(baseline)
Other Blood creatinine(Cr) levels Record preoperative Blood creatinine(Cr) levels before surgery(baseline)
Primary Confusion Assessment Method(CAM) Confusion Assessment Method to measure delirium before discharge from PACU
Primary Confusion Assessment Method(CAM) Confusion Assessment Method to measure delirium morning of the 1st day after surgery
Primary Confusion Assessment Method(CAM) Confusion Assessment Method to measure delirium afternoon of the 1st day after surgery
Primary Confusion Assessment Method(CAM) Confusion Assessment Method to measure delirium morning of the 2st day after surgery
Primary Confusion Assessment Method(CAM) Confusion Assessment Method to measure delirium afternoon of the 2st day after surgery
Primary Confusion Assessment Method(CAM) Confusion Assessment Method to measure delirium morning of the 3st day after surgery
Primary Confusion Assessment Method(CAM) Confusion Assessment Method to measure delirium afternoon of the 3st day after surgery
Secondary Quality of Recovery Score - 40 (QoR-40) Quality of recovery will be evaluated by Quality of Recovery 40 (QoR40),which assesses five dimensions of recovery (physical comfort,emotional state, physical independence , physiological support and pain ). Each item is rated on a five-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score on the QoR40 ranges from 40 (poorest quality of recovery) to 200 (best quality of recovery). 1 day before surgery(baseline)
Secondary Quality of Recovery Score - 40 (QoR-40) Quality of recovery will be evaluated by Quality of Recovery 40 (QoR40),which assesses five dimensions of recovery (physical comfort,emotional state, physical independence , physiological support and pain ). Each item is rated on a five-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score on the QoR40 ranges from 40 (poorest quality of recovery) to 200 (best quality of recovery). 1 day after surgery
Secondary Numerical Rating Scale(NRS) Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain. before discharge from PACU
Secondary Numerical Rating Scale(NRS) Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain. morning of the 1st day after surgery
Secondary Numerical Rating Scale(NRS) Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain. afternoon of the 1st day after surgery
Secondary Numerical Rating Scale(NRS) Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain. morning of the 2st day after surgery
Secondary Numerical Rating Scale(NRS) Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain. afternoon of the 2st day after surgery
Secondary Numerical Rating Scale(NRS) Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain. morning of the 3st day after surgery
Secondary Numerical Rating Scale(NRS) Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain. afternoon of the 3st day after surgery
Secondary Mini-Mental score examination (MMSE) Mini-Mental score examination [MMSE] used for screening of dementia 1 day before surgery(baseline)
Secondary Mini-Mental score examination (MMSE) and Neuropsychological tests Mini-Mental score examination (MMSE) and Neuropsychological tests to measure cognitive function, including the Trail 6±1 days after surgery
Secondary Mini-Mental score examination (MMSE) and Neuropsychological tests Mini-Mental score examination (MMSE) and Neuropsychological tests to measure cognitive function, including the Trail one month after surgery
Secondary serum folic acid levels Record preoperative serum folic acid levels 1 day before surgery(baseline)
Secondary serum vitamin B12 levels Record preoperative serum vitamin B12 levels 1 day before surgery(baseline)
Secondary serum homocysteine content Record preoperative serum homocysteine content 1 day before surgery(baseline)
Secondary serum branched chain amino acid content Record preoperative serum branched chain amino acid content 1 day before surgery(baseline)
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A